Skip to main content
. 2022 Feb 3;11(4):e022833. doi: 10.1161/JAHA.121.022833

Figure 5. Kaplan‐Meier curves of the composite outcome at 2.5 years against baseline NT‐proBNP concentration ranges in patients with (A) neither AF nor HF, (B) AF only, (C) HF only, (D) AF plus HF.

Figure 5

AF atrial fibrillation; HF heart failure; and NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.